跳至主要内容
临床试验/NCT01972906
NCT01972906已完成早期 1 期

Traditional Chinese Moxibustion for Primary Dysmenorrhea

Chengdu University of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 152 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
152
试验地点
1
主要终点
change from baseline in menstrual pain intensity measured by VAS at 6 months

研究概览

简要总结

Hypothesis: Moxibustion is effective for managing primary dysmenorrhea. Aim: To attest the effectiveness and safety of moxibustion for primary dysmenorrhea. Design: A randomized controlled trial. 152 participants will be included. Two arms: moxibustion treatment group and ibuprofen control group.

详细描述

There is no convincing evidence for the efficacy of moxibustion for primary dysmenorrhea, due to low methodologic quality and small sample size. The investigators designed the random clinical trial to investigates the effectiveness of moxibustion in treating primary dysmenorrhea, the purpose of this study is to provide the research base of moxibustion efficacy. The investigators also examined the acceptability and any adverse effects associated with the use of moxibustion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
13 Years 至 35 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Clinical diagnosis of Guidelines of Primary dysmenorrhea clinical by the Society of Obstetricians and Gynaecologists of Canada
  • Menstrual cycle is regular (28±7) days
  • Syndrome differentiation of Traditional Chinese Medicine: Congealing cold-damp and Qi-stagnation and blood stasis
  • Mean value of ≥40mm during last 3 months
  • Informed consent form must be signed by patient or lineal relative

排除标准

  • Patients with secondary dysmenorrhea, which is caused by endometriosis, pelvic inflammation, myoma of uterus and so on
  • Patients who are unconscious and psychotic
  • Patients with serious primary illness or diseases of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on
  • Patients take prostaglandin synthetase inhibitors (PGSI) 2 weeks before inclusion
  • Pregnant women or women in lactation

研究组 & 干预措施

Moxibustion treatment group

Experimental

Apply traditional acupuncture to prevent the dysmenorrhea according to traditional Chinese medicine theory

干预措施: moxibustion (Device)

Medicine control group

Active Comparator

Ibuprofen Sustained Release Capsules will be penetrated for dysmenorrhea

干预措施: Ibuprofen Sustained Release Capsules (Drug)

结局指标

主要结局

change from baseline in menstrual pain intensity measured by VAS at 6 months

时间窗: at baseline, 1st, 2nd, 3rd, 4th, 5th, 6th menstrual cycle after inclusion

to assess the degree of dysmenorrhea

次要结局

  • Laboratory index-1(at baseline, 4th menstrual cycle after inclusion)
  • Laboratory Index-4(at baseline, 4 menstrual cycles after inclucion)
  • Laboratory Index-2(at baseline, 4 menstrual cycles after inclusion)
  • Laboratory Index-5(at baseline, 4 menstrual cycles after inclusion)
  • Cox Menstrual Symptom Scale Cox Menstrual Symptom Scale(1st, 2nd, 3rd, 4th, 5th, 6th, 7th menstrual cycle after inclusion)
  • Laboratory Index-6(at baseline, 4 menstrual cycles after inclusion)
  • Laboratory Index-3(at baseline, 4 menstrual cycles after inclusion)

研究者

发起方
Chengdu University of Traditional Chinese Medicine
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验